SMARCC2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.756400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.843400E-01
Normal-vs-Stage2
5.280800E-01
Normal-vs-Stage3
6.557900E-02
Normal-vs-Stage4
8.523800E-01
Stage1-vs-Stage2
5.546400E-02
Stage1-vs-Stage3
1.847960E-02
Stage1-vs-Stage4
4.054600E-01
Stage2-vs-Stage3
3.708500E-02
Stage2-vs-Stage4
6.240200E-01
Stage3-vs-Stage4
3.457500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.287200E-01
Normal-vs-AfricanAmerican
3.419200E-01
Normal-vs-Asian
3.574800E-01
Caucasian-vs-AfricanAmerican
5.362200E-01
Caucasian-vs-Asian
2.359000E-01
AfricanAmerican-vs-Asian
7.891000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.993600E-01
Normal-vs-Female
5.345600E-01
Male-vs-Female
1.804360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.589000E-01
Normal-vs-Age(41-60Yrs)
9.973200E-01
Normal-vs-Age(61-80Yrs)
5.651000E-01
Normal-vs-Age(81-100Yrs)
2.625800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.376030E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.074200E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.068300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.598370E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.590100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.147000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.324000E-01
Normal-vs-Daily Drinker
6.230600E-01
Normal-vs-Weekly Drinker
4.320200E-01
Normal-vs-Occasional Drinker
6.585200E-01
Normal-vs-Social Drinker
7.588600E-01
Non Drinker-vs-Daily Drinker
3.240000E-01
Non Drinker-vs-Weekly Drinker
9.030200E-01
Non Drinker-vs-Occasional Drinker
8.020400E-03
Non Drinker-vs-Social Drinker
1.654810E-01
Daily Drinker-vs-Weekly Drinker
5.035200E-01
Daily Drinker-vs-Occasional Drinker
7.969800E-02
Daily Drinker-vs-Social Drinker
6.584400E-01
Weekly Drinker-vs-Occasional Drinker
5.033500E-02
Weekly Drinker-vs-Social Drinker
2.964400E-01
Occasional Drinker-vs-Social Drinker
1.945200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.013780E-01
Normal-vs-Grade 2
4.678200E-03
Normal-vs-Grade 3
3.581500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.538200E-01
Grade 1-vs-Grade 3
4.404600E-01
Grade 1-vs-Grade 4
1.013780E-01
Grade 2-vs-Grade 3
4.379000E-01
Grade 2-vs-Grade 4
4.678200E-03
Grade 3-vs-Grade 4
3.581500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.777000E-01
Normal-vs-NonDiabetic
7.624400E-01
Diabetic-vs-NonDiabetic
2.376000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.803600E-01
Normal-vs-NoPancreatitis
6.573400E-01
Pancreatitis-vs-NoPancreatitis
6.361400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.125800E-01
Normal-vs-N1
5.266200E-01
N0-vs-N1
3.946800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.378200E-01
Normal-vs-TP53-NonMutant
9.924600E-01
TP53-Mutant-vs-TP53-NonMutant
8.068000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
